The Hypothalamic-Pituitary-Adrenal Stress Axis in the Fibromyalgia Syndrome

References

• Chrousos GP, Gold PW: The concepts of stress and stress system disorders: Overview of physical and behavioral homeostasis. JAMA 267: 1244–1252, 1992.
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Suemaru S, Takao T, Sugawara M, Makino S, Ota Z; Corti-cotropin-releasing hormone and pituitary-adrenocortical responses in chronically stressed rats. Regulatory Peptides 23: 117–126, 1988.
   PubMedGoogle Scholar
• Scaccionoce S, Muscolo LAA, Cigliana G, Navarra D, Nicolai R, Ange-lucci L: Evidence for a specific role of vasopressin in sustaining pituitary-adreno-cortical stress response in the rat. Endocrinology 128: 3138–3143, 1991.
   PubMed Web of Science ®Google Scholar
• de Goeij DCE, Kvetnansky R, Whitnall MH, Jczova D, Berkenbosch F, Tilders FJH: Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats. Neuroendocrinology 53: 150–159, 1991.
   PubMed Web of Science ®Google Scholar
• Dallman MF, Akana SF, Levin N, Walker C-D, Bradbury MJ, Sucmara S, Scribner KS: Corticosteroids and the control of function in the hypothalamo-pitu-itary-adrenal (HPA) axis. Ann NY Acad Sci 746: 22–31, 1994.
   PubMed Web of Science ®Google Scholar
• Meaney MJ, Diorio J, Francis D, LaRocque S, O'Donnell D, Smythe JW, Sharma S, Tannenbaum B: Environmental regulation of the development of glu-cocorticoid receptor systems in the rat forebrain. Ann NY Acad Sci 746: 260–273, 1994.
   PubMed Web of Science ®Google Scholar
• Meaney MJ, Bhatnagar S, Larocque S, McCormick C, Shanks N, Sharma S, Smythe J, Viau V, Plotsky PM: Individual differences in the hypothalamic-pitu-itary-adrenal stress response and the hypothalamic CRF system. Ann NY Acad Sci 697: 70–85, 1993.
   PubMed Web of Science ®Google Scholar
• Plotsky PM, Meaney MJ: Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) RNA, median eminence CRF content and stress-induced release in adult rats. Mol Brain Res 18: 195–200, 1993.
   PubMedGoogle Scholar
• Shanks N, Larocque S, Meaney MJ: Neonatal endotoxin exposure alters the development of the hypothalamic-pituitary-adrenal axis: early illness and later responsivity to stress. J Neuroscience 15: 376–384, 1995.
   PubMed Web of Science ®Google Scholar
• Heiman JP, Schafer MK, Young EA, Thompson R, Douglass J, Akil H, Wat-son SJ: Evidence for hippocampal regulation of neuroendocrine neurons of the hy-pothalamo-pituitary-adrenocortical axis. J Neurosci 9(9): 3072–3082, 1989.
   PubMed Web of Science ®Google Scholar
• Sapolsky RM, Armanini MP, Packan DR, Sutton SW, Plotsky PM: Gluco-corticoid feedback inhibition of adrenocorticotropic hormone secretagogue re-lease: relationship to corticosteroid receptor occupancy in various limbic sites. Neuroendocrinology 51: 328–336, 1990.
   PubMed Web of Science ®Google Scholar
• Crofford LJ: Neuroendocrine aspects of fibromyalgia. J Musculoske Pain 2(3): 125–132, 1994.
   Google Scholar
• Demitrack MA, Crofford LJ: Hypothalamic-pituitary-adrenal axis dysreg-ulation in fibromyalgia and chronic fatigue syndrome: An overview and hypothe-sis. J Musculoske Pain 3(2): 67–73, 1995.
   Google Scholar
• Yunus MB, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL: Primary fi-bromyalgia (fibrositis): clinical study of 50 patients with matched normal con-trols. Semin. Arthritis Rheum 11: 151–171, 1981.
   Google Scholar
• Dailey PA, Bishop GD, Russell IJ, Fletcher EM: Psychological stress and the fibrositis/fibromyalgia syndrome. J Rheum 17: 1380–1385, 1990.
   PubMed Web of Science ®Google Scholar
• Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJP, Chrousos GP, Gold PW: Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin End Metab 73: 1224–1234, 1991.
   PubMed Web of Science ®Google Scholar
• Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA, Sternberg EM, Gold PW, Chrousos GP, Wilder RL: Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 37: 1583–1592, 1994.
   PubMed Web of Science ®Google Scholar
• McCain GA, Tilbe KS: Diurnal hormone variation in fibromyalgia syn-drome: A comparison with rheumatoid arthritis. J Rheum 16 (Suppl 19): 154–157, 1989.
   Google Scholar
• Griep EN, Boersma JW, de Kloet EP: Altered reactivity of the hypothalam-ic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheum 20: 469–474, 1993.
   PubMed Web of Science ®Google Scholar
• van Denderen JC, Boersma JW, Zeinstra P, Hollander AP, van Neerbos BR: Physiological effects of exhaustive physical exercise in primary fibromyalgia syn-drome (PFS): Is PFS a disorder of neuroendocrine reactivity? Scand J Rheumatol 21:35–37, 1992.
   PubMed Web of Science ®Google Scholar
• Sternberg EM: Hypoimmune fatigue syndromes: Diseases of the stress re-sponse? J Rheum 20: 418–421, 1993.
   PubMed Web of Science ®Google Scholar
• Patchev VK, Kalogeras KT, Zelazowski P, Wilder RL, Chrousos GP: In-creased plasma concentration, hypothalamic content, and in vitro release of argi-nine vasopressin in inflammatory disease-prone, hypothalamic corticotropin-re-leasing hormone-deficient Lewis rats. Endocrinology 131: 1453–1457, 1992.
   PubMed Web of Science ®Google Scholar
• Swain MG, Patchev V, Vergella J, Chrousos G, Jones EA: Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis. J Clin Invest 91: 1903–1908, 1993.
   PubMed Web of Science ®Google Scholar
• Sarlis NJ, Chowdrey HS, Stephanou A, Lightman SL: Chronic activation of the hypothalamo-pituitary-adrenal axis and loss of circadian rhythm during ad-juvant-induced arthritis in the rat. Endocrinology 130: 1775–1779, 1992.
   PubMed Web of Science ®Google Scholar
• Harbuz MS, Rees RG, Eckland D, Jessop DS, Brewerton D, Lightman SL: Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) mes-senger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proop-iomelanacortin mRNA during chronic inflammatory stress. Endocrinology 130(3): 1394–1400, 1992.
   Google Scholar
• Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW, Wilder RL: Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci USA 86: 2374–2378, 1989.
   PubMed Web of Science ®Google Scholar
• Sternberg EM, Young III WS, Bemardini R, Calogero AE, Chrousos GP, Gold PW, Wilder RL: A central nervous system defect in biosynthesis of cortico-tropin-releasing hormone is associated with susceptibility to streptococcal cell wall arthritis in Lewis rats. Proc Natl Acad Sci USA 86: 4771–4775, 1989.
   PubMed Web of Science ®Google Scholar
• Patchev VK, Mastorakos G, Brady LS, Redwine J, Wilder RL, Chrousos GP: Increased arginine vasopressin secretion may participate in the enhanced sus-ceptibility of Lewis rats to inflammatory disease. Neuroendocrinology 5,8: 106–110,1993.
   Google Scholar
• Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC: Plasma and urinary catecholamines in primary fibromyalgia: A controlled study. J Rheum 19: 95–97, 1992.
   PubMed Web of Science ®Google Scholar
• Russell IJ: Neurohormonal aspects of fibromyalgia syndrome. Rheum Dis Clin N Am 15: 149–168, 1989.
   PubMed Web of Science ®Google Scholar
• Vaeroy H, Qiao Z-G, Morkrid L, Forre 0: Altered sympathetic nervous system response in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 16: 1460–1465, 1989.
   PubMed Web of Science ®Google Scholar
• Qiao Z-G, Vaeroy H, Morkrid L: Electrodermal and microcirculatory ac-tivity in patients with fibromyalgia during baseline, acoustic stimulation and cold pressor tests. J Rheumatol 18: 1383–1389, 1991.
   PubMed Web of Science ®Google Scholar
• Elam M, Johansson G, Wallin BG: Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity? Pain 48: 371–375, 1992.
   PubMed Web of Science ®Google Scholar
• Lundberg JM, Franco-Cereceda A, Lacroix J-S, Pernow J: Neuropeptide Y and sympathetic neurotransmission. Ann NY Acad Sci 611: 166–174, 1990.
   PubMed Web of Science ®Google Scholar
• Clauw DJ, Sabol M, Radulovic D, Wilson B, Katz P, Baraniuk J: Serum neuropeptides in patients with both fibromyalgia (FM) and chronic fatigue syn-drome (CFS). J Musculoske Pain 3 (Suppl 1): 79, 1995.
   Google Scholar
• Irwin M, Brown M, Patterson T, Hauger R, Mascovich A, Grant I: Neuro-peptide Y and natural killer cell activity: findings in depression and Alzheimer caregiver stress. FASEB J 5:3100–3107, 1991.
   PubMed Web of Science ®Google Scholar
• Allen YS, Adrian RE, Allen JM, Tatemoto K, Crow TJ, Bloom SR, Polak JM: Neuropeptide Y distribution in the rat brain. Science 221: 877–879, 1983.
   PubMed Web of Science ®Google Scholar
• De Quidt ME, Emson PC: Distribution of neuropeptide Y-like immuno-reactivity in the rat central nervous system-II. Immunohistochemical analysis. Neuroscience 18: 545–618, 1986.
   PubMed Web of Science ®Google Scholar
• Haas DA, George SR: Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: lack of effect in other rat brain regions. Life Sci 41: 2725–2731, 1987.
   PubMed Web of Science ®Google Scholar
• Koenig JI: Regulation of the hypothalamo-pituitary axis by neuropeptide Y. Ann NY Acad Sci 611: 317–328, 1990.
   PubMedGoogle Scholar
• Kamilaris TC, Calogero AE, Johnson EO: Effect of neuropeptide Y on hy-pothalamic-pituitary-adrenal function in the rat. 19th Annual Meeting of the Soci-ety for Neuroscience, Phoenix, AZ, 1989.
   Google Scholar
• Russell IJ: Neurohormonal: Abnormal laboratory findings related to pain and fatigue in fibromyalgia. J Musculoske Pain 3(2): 59–65, 1995.
   Google Scholar
• Krieger DT, Rizzo F: Serotonin mediation of circadian periodicity of plas-ma 17-hydroxycorticosteroids. Am J Physiol 217: 1703–1707, 1969.
   PubMed Web of Science ®Google Scholar
• Scapagnini U, Moberg GP, Van Loon GR, de Groot J, Ganong WF: Rela-tion of brain 5-hydroxytryptamine content to the diurnal variation of plasma corti-costerone in the rat. Neuroendocrinology 7: 90–96, 1971.
   PubMed Web of Science ®Google Scholar
• Jones MT, Hillhouse EW, Burden J: Effect of various putative neurotrans-mitters on the secretion of corticotropin-releasing hormone from the rat hypothala-mus in vitro: a model of the neurotransmitters involved. J Endocrinol 69: 1–10, 1976.
   PubMed Web of Science ®Google Scholar
• Buckingham C, Hodges JR: Hypothalamic receptors influencing the secre-tion of corticotropin-releasing hormone in the rat. J Physiol 290: 421–431, 1979.
   PubMed Web of Science ®Google Scholar
• Holmes MC, DiRenzy G, Gillham B, Jones MT: Role of serotonin in the control of secretion of corticotropin-releasing factor. J Endocrinol 93: 151–160, 1982.
   PubMed Web of Science ®Google Scholar
• Burnett PWJ, Mefford IN, Smith CC, Gold PW, Sternberg EM: Hippocam-pal 8-[3H]hydroxy-2-(di-n-propylamino)tetralin binding site densities, serotonin receptor (5HT1A) messenger ribonucleic acid abundance, and serotonin levels parallel the activity of the hypothalamopituitary-adrenal axis in rat. J Neurochem 59(3): 1062–1070, 1992.
   Google Scholar
• Yehuda R, Meyer JS: A role for serotonin in the hypothalamic-pituitary-adrenal response to insulin stress. Neuroendocrinology 38: 25–32, 1984.
   PubMed Web of Science ®Google Scholar
• Wasman J, Zatzkis SM: Fibromyalgia and menopause: Examination of the relationship. Postgrad Med 80: 165–171, 1986.
   Web of Science ®Google Scholar
• Vamvakopoulos NC, Chrousos GP: Evidence of direct extrogenic regula-tion of human corticotropin-releasing hormone gene expression. J Clin Invest 92: 1896–1902, 1993.
   PubMed Web of Science ®Google Scholar
• Young EA: The role of gonadal steroids in hypothalamic-pituitary-adrenal axis regulation. Critical Reviews in Neurobiol. In Press.
   Google Scholar
• Young EA, Kotun J, Haskett RF, Grunhaus L, Greden JF, Watson SJ, Akil H: Dissociation between pituitary and adrenal suppression to dexamethasone in depression. Arch Gen Psychiatry 50: 395–403, 1993.
   PubMed Web of Science ®Google Scholar
• Griep EN, Boersma JW, de Kloet ER: Pituitary release of growth hormone and prolactin in the primary fibromyalgia syndrome. J Rheun-tatol 21: 2125–2130, 1994.
   PubMed Web of Science ®Google Scholar
• Bennett RM, Clark SR, Campbell SM, Burckhardt CS: Low levels of so-matomedin C in patients with the fibromyalgia syndrome. Arthritis Rheum 35: 1113–1116, 1992.
   PubMed Web of Science ®Google Scholar
• Bennett RM, Clark SR, Burckhardt CS, Cook D: IGF-1 assays and other GH tests in 500 fibromyalgia patients. J Musculoske Pain 3 (Suppl 1): 109, 1995.
   Google Scholar
• Sternberg EM, Glowa JR, Smith MA, Calogero AE, Listwak SJ, Aksentije-vich S, Chrousos GP, Wilder RL, Gold PW: Corticotropin-releasing hormone-re-lated behavioral and neuroendocrine responses to stress in Lewis and Fischer rats. Brain Res 570: 54–60, 1992.
   PubMed Web of Science ®Google Scholar
• Vaeroy H, Helle R, Foffe 0, lass E, Terenius L: Cerebrospinal fluid levels of-endorphin in patients with fibromyalgia (fibrositis syndrome). J Rheum 15: 1804–1806, 1988.
   PubMed Web of Science ®Google Scholar
• Yunus MB, Denko CW, Masi AT: Serum beta endorphin in primary fibro-myalgia syndrome: A controlled study. J Rheumatol 13: 183–186, 1986.
   PubMed Web of Science ®Google Scholar